| Head of Urologic Pathology Committee, Gustave Roussy Institute, France. Head of International Academic Network, Gustave Roussy Institute, France. Professor, Oncology, University of Paris-Saclay,France Medical oncologist at Gustave Roussy, specializing in the management of prostate cancer, Professor Karim Fizazi is a professor of oncology at the University of Paris-Saclay. He was head of the department of oncology medicine. Karim Fizazi is leading major studies in oncology as of the LATITUDE study that changed the treatment of newly diagnosed patients with metastatic prostate cancer. He is leading the ARAMIS trial in high-risk non-metastatic castration-resistant prostate cancer. Prof. Fizazi established the Prostate Cancer Consortium in Europe (PEACE) and leads the first two large European Phase III trials: PEACE-1 and PEACE-2. He is also the Associate Editor of the European Journal of Cancer and has authored over 300 scientific publications. |